ArticleHaematologica2015

Tyrosine kinase inhibitors improve long-term outcome of allogeneic hematopoietic stem cell transplantation for adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia.

Eolia Brissot et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.